Enhanced Recovery After Surgery in Cytoreductive Surgery With HIPEC: Implementation and Outcomes From a High‐Volume Tertiary Centre in a Lower‐Middle Income Country

Key Points

• To evaluate the feasibility and safety of an Enhanced Recovery After Surgery (ERAS) pathway for cytoreductive surgery with HIPEC in a lower-middle income country.
• Implemented the ERAS pathway for CRS-HIPEC procedures.
• Conducted the study in a high-volume tertiary center.
• Monitored hospital stay duration, morbidity, and mortality rates.
• Patients experienced shorter hospital stays after surgery.
• The ERAS pathway did not increase morbidity or mortality rates.
• Implementation was deemed feasible and safe in the local context.

Abstract